文献速递颈动脉与弓上血管

术前贫血是颈动脉血运重建术后不良结局的独立预测因素

Anemia as an independent predictor of adverse outcomes after carotid revascularization.
PubMed 文献 · J Vasc Surg · 2020-04-02

该研究基于血管质量倡议(VQI)数据库2012年1月至2018年6月接受颈动脉内膜剥脱术(CEA)和颈动脉支架置入术(CAS)的102,719例患者,评估术前贫血与院内主要不良心脏事件(MACE)及30天死亡率的关系。结果显示贫血患者院内MACE(2.8% vs 1.9%)和30天死亡率(0.9% vs 0.4%)均更高,多因素分析提示贫血与不良结局独立相关。

要点

  • 术前贫血与CEA和CAS术后院内MACE及30天死亡率升高相关。
  • 贫血的定义为女性血红蛋白<12 g/dL、男性<13 g/dL。
  • 建议将术前贫血纳入颈动脉血运重建患者的术前风险评估。

核心结论

  • 贫血与CEA和CAS术后不良事件风险升高相关,应纳入颈动脉血运重建患者的术前风险评估。
  • 纠正术前低血红蛋白的疗效及贫血与长期结局的关系尚需前瞻性研究。

研究设计与样本

  • 基于血管质量倡议(VQI)数据库的回顾性队列研究。
  • 纳入2012年1月至2018年6月接受CEA和CAS的患者共102,719例。
  • 采用多因素logistic分析和1:1粗化精确匹配分析贫血与结局的关联。

主要发现

  • 贫血患者占34.8%(CEA 34.1%,CAS 37.8%,P < .001)。
  • 贫血患者院内MACE发生率为2.8% vs 1.9%(P < .001),30天死亡率为0.9% vs 0.4%(P < .001)。
  • 多因素分析显示贫血与院内MACE风险升高18%相关(OR 1.18;95%CI 1.07-1.31,P = .001)。
  • 多因素分析显示贫血与30天死亡风险升高74%相关(OR 1.74;95%CI 1.40-2.17,P < .001)。
  • 粗化精确匹配结果相似,且CAS与CEA、有症状与无症状患者间关联一致(P交互 > .05)。

关键数值与推荐

  • 贫血定义:术前女性血红蛋白<12 g/dL、男性<13 g/dL。
  • 主要结局为院内MACE(卒中、死亡和心肌梗死的复合终点)及30天死亡率。

临床怎么用

  • 对拟行CEA或CAS的患者术前应评估血红蛋白水平,并将贫血纳入风险分层。
  • 贫血患者围手术期可能需要更严密监测,但是否纠正贫血尚无证据支持。

局限性

  • 为回顾性数据库研究,可能存在未测量混杂。
  • 未评估纠正术前贫血的疗效及长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anemia has been identified as a risk factor for postoperative morbidity and mortality after major vascular procedures. Carotid revascularization carries less cardiac morbidity and physiologic stress compared with other vascular interventions. This study evaluated the association between preoperative anemia and major adverse events after carotid revascularization. METHODS: Patients undergoing carotid endarterectomy (CEA) and carotid artery stenting (CAS) between January 2012 and June 2018 in the Vascular Quality Initiative database were identified. Anemia was defined as a preoperative hemoglobin level of <12 g/dL in women and <13 g/dL in men. Multivariable logistic analysis and 1:1 coarsened exact matching were used to study the association between preoperative anemia and in-hospital major adverse cardiac events (MACEs), defined as a composite of stroke, death, and myocardial infarction, and between anemia and 30-day mortality after CEA and CAS. RESULTS: Of 102,719 patients included in the analysis, 34.8% were anemic (CEA, 34.1%; CAS, 37.8%; P < .001). Anemic patients were older and had more medical comorbidities compared with nonanemic patients. In-hospital MACEs (2.8% vs 1.9%; P < .001) and 30-day mortality (0.9% vs 0.4%; P < .001) were higher among anemic patients. On multivariable analysis, anemia was associated with 18% higher odds of in-hospital MACEs (odds ratio, 1.18; 95% confidence interval, 1.07-1.31, P = .001) and 74% higher odds of 30-day mortality (odds ratio, 1.74; 95% confidence interval, 1.40-2.17, P < .001). Coarsened exact matching showed similar results. The association between preoperative anemia and adverse outcomes was similar in both CAS and CEA and in symptomatic and asymptomatic patients (P interaction > .05). CONCLUSIONS: Anemia is associated with increased odds of adverse events after CEA and CAS. It should be factored into the preoperative risk assessment of patients undergoing carotid revascularization. Prospective studies are needed to study the effectiveness of correcting low preoperative hemoglobin levels in these patients and the association between anemia and long-term outcomes after CEA and CAS.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dakour-Aridi H, Ou MT, Locham S, et al. Anemia as an independent predictor of adverse outcomes after carotid revascularization. J Vasc Surg. 2020. PMID: 32249047. doi:10.1016/j.jvs.2020.01.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。